binx health

binx health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer. binx is developing a suite of offerings that service healthcare needs where people live, work and shop. The Company’s io® platform is designed to offer rapid PCR-based results, up to 24-plex, from sample-in-to-answer in about 30 minutes, greatly accelerating today’s multiple day standard-of-care central lab testing paradigm. binx is driving solutions to take place in retail clinics, supermarkets, primary care offices, and at home. It does it through a suite of mobile and digital offerings. binx health investors includes financial investors, Johnson & Johnson Innovation, Novartis Venture Fund, LSP Venture Capital, BB Biotech, RMI Investments and Technology Venture Partners and strategic investors, Consort Medical (whose wholly owned subsidiary Bespak are the makers of the company’s low-cost, proprietary multi-plex cartridges) and China-based Wondfo Biotech. binx health is a global company and has locations in Boston, MA and Bath UK. For further information visit www.mybinxhealth.com.

https://mybinxhealth.com

51-200 employees

Growth Trajectory

binx health is poised for growth through continued expansion of its point-of-care testing programs nationally and through partnerships with state health departments and corporate entities. Further development of at-home testing solutions and digital integration capabilities presents additional opportunities for market expansion and increased accessibility to care. The company's focus on innovation in molecular diagnostics and digital health platforms should contribute to sustainable growth.

Technical Challenges

Tech Stack

Team Size

Key Risks

Increasing competition in the digital health and diagnostics market.

Potential challenges in transitioning from pandemic to endemic COVID-19 management.

Maintaining compliance with evolving FDA and CLIA regulations.

Addressing potential issues regarding compliance with laws, treaties, conventions, protocols, regulations, ordinances, codes, standards, directives, orders and rules issued by governmental agencies or authorities, which are applicable in any way to the activities relating to this Order or the manufacture, labeling, transportation, importation, exportation, licensing, certification, or approval of the Products or the chemical substances contained therein

Opportunities

Expanding partnerships with healthcare providers and public health organizations to increase testing access.

Developing multiplex platforms for simultaneous diagnosis of multiple pathogens to improve efficiency.

Leveraging digital integration capabilities to streamline healthcare workflows and enhance patient engagement.

Further developing at-home testing solutions and integrating them with telehealth services.

Expanding into new geographic markets, particularly in areas with limited access to testing.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats

Access Database

Updated every 5 minutes